The current valuation score of Evotec SE is 8.49, ranking 129 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.11, which is -2.29% below the recent high of -4.02 and -990.37% above the recent low of -44.85.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.